Cancer treatment resumption in patients with new-generation drug-eluting stents.

Coronary Artery Disease
Dinu Valentin BalanescuCezar A Iliescu

Abstract

Percutaneous coronary intervention (PCI) with new-generation drug-eluting stents (DESs) may provide survival benefits to the cancer population undergoing PCI by expediting cancer treatment due to improved safety profile. We aimed to assess the safety of starting or resuming cancer treatment within 6 months of DES placement. We also compared the impact of different DES types on the overall survival (OS) in cancer patients and to identify a safe threshold for dual antiplatelet therapy (DAPT) discontinuation. Cancer patients at our institution undergoing PCI with DES from December 2014 to June 2017 were included. Baseline demographics, DAPT duration, malignancy type, stage, and treatment were retrospectively analyzed. Univariate Cox regression was used to pinpoint baseline characteristics that correlated with OS. Survivorship was determined by Kaplan-Meier analysis, and the log-rank test was used to compare OS among DES types. Seventy-five patients were included. Of these, 45 had biodegradable polymer DES (Synergy) and 30 patients had durable polymer DES (Resolute Integrity, Xience, Ion, or Promus). Mean duration of follow-up was 1367 ± 334 days. There were two minor bleeding complications. No statistically significant differences...Continue Reading

Associated Clinical Trials

References

Feb 14, 2007·The New England Journal of Medicine·Gregg W StoneMartin B Leon
Mar 22, 2008·Journal of the American College of Cardiology·C Michael GrossCemil Ozcelik
Apr 18, 2009·Journal of the American College of Cardiology·Jochem W van WerkumJurriën M ten Berg
Aug 24, 2010·Progress in Cardiovascular Diseases·Ronald J Krone
Jul 25, 2012·Proceedings of the National Academy of Sciences of the United States of America·Mélanie DemersDenisa D Wagner
Dec 4, 2012·International Journal of Cardiology·Satoshi KurisuYasuki Kihara
Sep 2, 2015·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Sang Hyuck KimJong-Hyock Park
Dec 23, 2015·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Olivier VarennePeter Sinnaeve
Sep 14, 2016·Coronary Artery Disease·Uri LandesZaza Iakobishvili
Apr 20, 2017·Current Oncology Reports·Dana Elena GizaCezar Iliescu
Nov 25, 2017·JACC. Cardiovascular Interventions·Sarju GanatraMichael S Levy
Feb 14, 2019·The International Journal of Cardiovascular Imaging·Dinu Valentin BalanescuCezar Iliescu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Related Papers

American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Jade E Basaraba, Arden R Barry
© 2021 Meta ULC. All rights reserved